dual agonist glp 1 glucagon GLP-1R and Diabetes New strategies for the treatment
Description
Looking Ahead The increasing popularity of GLP-1 agonists outside traditional diabetic populations means emergency physicians will continue to see complications from these agents
Excessive Weight Loss and Risk of Malnutrition
Purinergic Signal
Underestimation of the maximal capacity of the mitochondrial electron transport system in oligomycin-treated cells
The stomach timing problem GLP-1 medications slow the rate at which food and liquid leave the stomach like a funnel with a narrower opening
All analyses were conducted on previously published studies and publicly available data
